Where to Buy Aumolertinib？

About Aumolertinib

Aumolertinib (previously known as almonertinib) is a EGFR tyrosine kinase inhibitor targeting EGFR-sensitizing and T790M resistance mutations.It is being investigated against advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC).

In March 2020 aumolertinib was approved in China, on the basis of APOLLO (ClinicalTrials.gov identifier: NCT0298110), for the treatment of patients with advanced NSCLC and an EGFR T790M mutation.

Where to Buy Aumolertinib？

Aumolertinib, marketed as
Ivesa (Chinese Brand name :阿美乐). Currently only available for purchase in Mainland China.

You can also consult us: @RxLibra